Stryker delves further into stroke devices with $135M purchase

Stryker of Kalamazoo, Mich., will acquire Concentric Medical in an all cash transaction for $135 million.

The Mountain View, Calif.-based Concentric manufactures and markets minimally invasive products for treatment of acute ischemic stroke. Its products include devices for removal of thrombus in patients experiencing acute ischemic stroke, and the company has a scheduled clinical trial in the U.S. for a clot-removal product, the Trevo Retriever device.

The transaction is expected to be neutral to Stryker’s 2011 earnings per share, according to the release, and is expected to close in the fourth quarter of 2011.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.